umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Adverse events in apheresis: an update of the WAA registry data
Umeå University, Faculty of Medicine, Department of Public Health and Clinical Medicine, Medicine.
Show others and affiliations
2016 (English)In: Transfusion and apheresis science, ISSN 1473-0502, E-ISSN 1878-1683, Vol. 54, no 1, 2-15 p.Article, review/survey (Refereed) Published
Abstract [en]

Apheresis with different procedures and devices are used for a variety of indications that may have different adverse events (AEs). The aim of this study was to clarify the extent and possible reasons of various side effects based on data from a multinational registry. The WAA-apheresis registry data focus on adverse events in a total of 50846 procedures in 7142 patients (42% women). AEs were graded as mild, moderate (need for medication), severe (interruption due to the AE) or death (due to AE). More AEs occurred during the first procedures versus subsequent (8.4 and 5.5%, respectively). AEs were mild in 2.4% (due to access 54%, device 7%, hypotension 15%, tingling 8%), moderate in 3% (tingling 58%, urticaria 15%, hypotension 10%, nausea 3%), and severe in 0.4% of procedures (syncope/hypotension 32%, urticaria 17%, chills/fever 8%, arrhythmia/asystole 4.5%, nausea/vomiting 4%). Hypotension was most common if albumin was used as the replacement fluid, and urticaria when plasma was used. Arrhythmia occurred to similar extents when using plasma or albumin as replacement. In 64% of procedures with bronchospasm, plasma was part of the replacement fluid used. Severe AEs are rare. Although most reactions are mild and moderate, several side effects may be critical for the patient. We present side effects in relation to the procedures and suggest that safety is increased by regular vital sign measurements, cardiac monitoring and by having emergency equipment nearby.

Place, publisher, year, edition, pages
Elsevier, 2016. Vol. 54, no 1, 2-15 p.
Keyword [en]
Apheresis, Adverse events, Plasma, Albumin, Donor
National Category
Urology and Nephrology Hematology
Identifiers
URN: urn:nbn:se:umu:diva-120207DOI: 10.1016/j.transci.2016.01.003ISI: 000374614700002PubMedID: 26776481OAI: oai:DiVA.org:umu-120207DiVA: diva2:927154
Available from: 2016-05-11 Created: 2016-05-11 Last updated: 2017-01-17Bibliographically approved

Open Access in DiVA

fulltext(2161 kB)38 downloads
File information
File name FULLTEXT01.pdfFile size 2161 kBChecksum SHA-512
c15f7a64244c3bb20d88d86dae9162985ba1fdc819239392ddb9e0f68ba9390a9a83d88bc0729b9bac964e111ca1bb654f49f09593e2c40effc0b28bac62806e
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Mörtzell Henriksson, MonicaStegmayr, BerndRamsauer, Bernd
By organisation
Medicine
In the same journal
Transfusion and apheresis science
Urology and NephrologyHematology

Search outside of DiVA

GoogleGoogle Scholar
Total: 38 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 82 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf